United States Cardiac Arrest Treatment Market Size Worth US$ 24.69 Billion by 2031 | Rising Cardiovascular Disease Burden, AED Installations, and AI-Based Monitoring Driving 9.21% CAGR Growth

Global Cardiac Arrest Treatment Market size was valued at US$ 16,230 million in 2021 and is estimated to reach US$ 24,690 million by 2031, growing at a CAGR of 9.21% during the forecast period 2024-2031.

The Cardiac Arrest Treatment Market includes therapies, devices, and drugs designed to manage sudden cardiac emergencies. Automated external defibrillators (AEDs), CPR devices, antiarrhythmic drugs, and life-support technologies dominate the landscape. Rising cases of cardiovascular disorders due to sedentary lifestyles and aging populations are driving demand. Governments and hospitals are investing in emergency preparedness infrastructure. Public awareness programs are encouraging AED installations in schools, offices, and public spaces. Technological advancements, including AI-based monitoring, are improving patient survival outcomes significantly.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Cardiac Arrest Treatment Market Landscape:- https://datamintelligence.com/download-sample/cardiac-arrest-treatment-market?rk

☛ Cardiac Arrest Treatment Market Recent Developments 2025:

United States: Recent Developments

✅ In July 2025, researchers at the University of Michigan's Max Harry Weil Institute were awarded $5.5 million to develop an AI-integrated wearable sensor ("INSIGHT-CPR") that gives rescuers immediate feedback on CPR effectiveness by monitoring diastolic blood pressure.

✅ In September 2025, Neurescue received CE Mark approval in Europe for its intelligent balloon catheter device for non-shockable cardiac arrest, designed to redirect blood flow to the heart and brain during CPR.

✅ In September 2025, Neurescue also obtained FDA 510(k) clearance for hemorrhage control, alongside IDE approval to conduct a US clinical trial for its cardiac arrest indication.

Japan: Recent Developments

✅ In April 2023, a multicenter trial in Japan demonstrated that hydrogen gas inhalation after out-of-hospital cardiac arrest may significantly improve rates of neurologically intact survival.

✅ In July 2024, researchers at Osaka Metropolitan University introduced a prognostic scoring model ("R-EDByUS") based on prehospital resuscitation data, enabling rapid prediction of neurological outcomes in cardiac arrest patients.

☛ Cardiac Arrest Treatment Market Trends:

The cardiac arrest treatment market is experiencing growth due to increasing prevalence of cardiovascular diseases, aging populations, and sedentary lifestyles. Rising adoption of automated external defibrillators (AEDs) in public spaces, along with growing awareness of emergency care, is boosting the market.

Technological advancements in CPR devices, implantable cardioverter-defibrillators (ICDs), and wearable cardiac monitoring systems are driving innovation. Supportive government initiatives and improved emergency response infrastructure are also encouraging wider adoption of life-saving cardiac arrest treatment solutions.

☛ Cardiac Arrest Treatment Market Competitve Landscape:

Koninklijke Philips N.V., ZOLL Medical Corporation, GE Healthcare, Stryker, Boston Scientific Corporation, Cardiac Science Corporation (Aurora Capital Group), Bristol-Myers Squibb Company, and Abbott. among others.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/cardiac-arrest-treatment-market

☛ Segment Covered in the Cardiac Arrest Treatment Market:

By Treatment Type: Beta Blockers, Vasopressors, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs, and Others.

By Distribution Channel: Hospitals, Independent Pharmacies, and Others.

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Cardiac Arrest Treatment Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=cardiac-arrest-treatment-market

☛ Regional Analysis for Cardiac Arrest Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Cardiac Arrest Treatment Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Cardiac Arrest Treatment Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Cardiac Arrest Treatment Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.